chr3-38793970-C-A

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006514.4(SCN10A):​c.41G>T​(p.Arg14Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00265 in 1,613,936 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 6 hom. )

Consequence

SCN10A
NM_006514.4 missense

Scores

4
7
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.530
Variant links:
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.028188914).
BP6
Variant 3-38793970-C-A is Benign according to our data. Variant chr3-38793970-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 414623.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38793970-C-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 286 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN10ANM_006514.4 linkc.41G>T p.Arg14Leu missense_variant Exon 2 of 28 ENST00000449082.3 NP_006505.4 Q9Y5Y9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN10AENST00000449082.3 linkc.41G>T p.Arg14Leu missense_variant Exon 2 of 28 1 NM_006514.4 ENSP00000390600.2 Q9Y5Y9
SCN10AENST00000643924.1 linkc.41G>T p.Arg14Leu missense_variant Exon 1 of 27 ENSP00000495595.1 A0A2R8Y6J6
SCN10AENST00000655275.1 linkc.41G>T p.Arg14Leu missense_variant Exon 2 of 28 ENSP00000499510.1 A0A590UJM0

Frequencies

GnomAD3 genomes
AF:
0.00188
AC:
286
AN:
152156
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00207
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00297
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00194
AC:
486
AN:
250810
Hom.:
1
AF XY:
0.00174
AC XY:
236
AN XY:
135518
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000839
Gnomad ASJ exome
AF:
0.00954
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00111
Gnomad NFE exome
AF:
0.00279
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00274
AC:
3999
AN:
1461662
Hom.:
6
Cov.:
31
AF XY:
0.00263
AC XY:
1914
AN XY:
727140
show subpopulations
Gnomad4 AFR exome
AF:
0.000239
Gnomad4 AMR exome
AF:
0.000872
Gnomad4 ASJ exome
AF:
0.00907
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000151
Gnomad4 FIN exome
AF:
0.00118
Gnomad4 NFE exome
AF:
0.00308
Gnomad4 OTH exome
AF:
0.00339
GnomAD4 genome
AF:
0.00188
AC:
286
AN:
152274
Hom.:
0
Cov.:
32
AF XY:
0.00167
AC XY:
124
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.000409
Gnomad4 AMR
AF:
0.00144
Gnomad4 ASJ
AF:
0.00634
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00207
Gnomad4 NFE
AF:
0.00297
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00261
Hom.:
2
Bravo
AF:
0.00173
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00302
AC:
26
ExAC
AF:
0.00193
AC:
234
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00273
EpiControl
AF:
0.00284

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 22, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 24998131, 25691686, 25691538, 26733327, 28589536, 27761160, 27200363, 27446933, 24998132, 27272739, 28407228, 27711072, 30662450, 30821013, 31539150) -

Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SCN10A: BS1, BS2 -

not specified Benign:1
Jul 28, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Brugada syndrome 1 Benign:1
May 28, 2019
Mendelics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Brugada syndrome Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Episodic pain syndrome, familial, 2 Benign:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Mar 05, 2019
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
0.010
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.58
D;.;D;.
Eigen
Benign
0.11
Eigen_PC
Benign
-0.068
FATHMM_MKL
Benign
0.68
D
LIST_S2
Uncertain
0.86
.;D;D;D
M_CAP
Pathogenic
0.38
D
MetaRNN
Benign
0.028
T;T;T;T
MetaSVM
Pathogenic
0.84
D
MutationAssessor
Pathogenic
3.5
M;.;M;.
PrimateAI
Benign
0.23
T
PROVEAN
Uncertain
-3.8
D;.;.;.
REVEL
Pathogenic
0.84
Sift
Uncertain
0.0050
D;.;.;.
Sift4G
Uncertain
0.034
D;.;.;.
Polyphen
1.0
D;.;D;.
Vest4
0.54
MVP
0.87
MPC
0.26
ClinPred
0.047
T
GERP RS
2.3
Varity_R
0.38
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141207048; hg19: chr3-38835461; COSMIC: COSV101479360; API